ArticleNature medicine2022
A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project.
Abstract readLetter
In one paragraph
Article in Nature medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Re-evaluating CD57 as a marker of T cell senescence: implications for immune ageing and differentiation.Immunity & ageing : I & A · 2025Article
- Cytokine profile of anti-spike CD4iScience · 2024Article
- Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination.JAMA network open · 2024Article
- Review
- Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein.Vaccines · 2023Article
- Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.Scientific reports · 2022Article
- Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment.Therapeutic advances in respiratory diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors.
Diana MolinoUniversité Paris Cité, National Institute for Health and Medical Research (INSERM) CIC 1417 Cochin Pasteur, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France.ORCID http://orcid.org/0000-0002-2188-3880
Christine DurierINSERM SC10-US019, Villejuif, France.
Anne RadenneAP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière, Paris, France.
Corinne DesaintINSERM SC10-US019, Villejuif, France.
Jacques RopersAP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière, Paris, France.
Soizic CourcierUniversité Paris Cité, National Institute for Health and Medical Research (INSERM) CIC 1417 Cochin Pasteur, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France.
Louis Victorien VieillardUniversité Paris Cité, National Institute for Health and Medical Research (INSERM) CIC 1417 Cochin Pasteur, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France.
Claire RekacewiczUniversité Paris Cité, National Institute for Health and Medical Research (INSERM) CIC 1417 Cochin Pasteur, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France.
Beatrice ParfaitAP-HP, Hôpital Cochin, Fédération des Centres de Ressources Biologiques-Plateforme de Ressources Biologiques Centre de Ressources Biologique Cochin, Paris, France.
Victor AppayCentre Hospitalier Universitaire (CHU) Bordeaux, Laboratory of Immunology and Immunogenetics, Université de Bordeaux, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 5164, INSERM ERL 1303, ImmunoConcEpT, Bordeaux, France.
Frédéric BatteuxAP-HP, Hôpital Cochin, Service d'Immunologie Biologique et Plateforme d'Immunomonitoring Vaccinal, Paris, France.
Emmanuel BarillotInstitut Curie, PSL Research University-INSERM U900-MINES ParisTech, PSL, Paris, France.ORCID http://orcid.org/0000-0003-2724-2002
Michel CognéLaboratory of Immunology-Research Unit INSERM U 1236, B cell Ig Remodelling Singularities (BIGRES), Faculty of Medicine, French Blood Center (EFS Bretagne) & University Hospital, Rennes, France.
Béhazine CombadièreCentre d'Immunologie et des Maladies Infectieuses-Paris (Cimi-Paris), INSERM U1135, Sorbonne Université, Paris, France.
Christiane S EberhardtUniversity of Geneva, Faculty of Medicine, Division of General Pediatrics, Department of Woman, Child and Adolescent Medicine and Center for Vaccinology, Geneva, Switzerland.
Guy GorochovSorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Département d'Immunologie, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.ORCID http://orcid.org/0000-0003-2097-9677
Philippe HupéInstitut Curie, PSL Research University-INSERM U900-MINES ParisTech, PSL, Paris, France.ORCID http://orcid.org/0000-0001-8468-3424
Laetitia NinoveAix Marseille Université, Research Institute for Sustainable Development (IRD) 190, INSERM 1207, IHU Méditerranée Infection, Unité des Virus Émergents, Marseille, France.
Stéphane PaulINSERM, U1111, CNRS, UMR 530, Immunology and Immunomonitoring Laboratory, iBiothera, CIRI-GIMAP, UCBL 1, UJM, CIC 1408, Saint-Etienne, France.ORCID http://orcid.org/0000-0002-8830-4273
Isabelle PellegrinCentre Hospitalier Universitaire (CHU) Bordeaux, Laboratory of Immunology and Immunogenetics, Université de Bordeaux, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 5164, INSERM ERL 1303, ImmunoConcEpT, Bordeaux, France.
Sylvie van der WerfUniversité Paris Cité, Institut Pasteur, Unité Génétique Moléculaire Virus à ARN UMR 3569 CNRS, Paris, France.ORCID http://orcid.org/0000-0002-1148-4456
Maeva LefebvreCHU de Nantes, INSERM CIC1413, Maladies Infectieuses et Tropicales, Centre de Prévention des Maladies Infectieuses et Transmissibles, Nantes, France.
Elisabeth Botelho-NeversINSERM CIC 1408, Axe Vaccinologie, CHU de Saint-Etienne, Service d'Infectiologie, Saint-Etienne, France.
Inmaculada Ortega-PerezANRS | Emerging Infectious Diseases, Paris, France.
Marie JaspardThe Alliance for International Medical Action (ALIMA), Paris, France.
Samba SowThe Center for Vaccine Development, Bamako, Mali.
Jean Daniel LelièvreINSERM U955, Créteil, France, Vaccine research Institute, Créteil, France.
Xavier de LamballerieAix Marseille Université, Research Institute for Sustainable Development (IRD) 190, INSERM 1207, IHU Méditerranée Infection, Unité des Virus Émergents, Marseille, France.
Marie Paule KienyINSERM 101, Paris, France.
Eric TartourAP-HP, Hôpital Européen Georges Pompidou, INSERM U970, PARCC, Paris, France.ORCID http://orcid.org/0000-0002-7323-468X
Odile LaunayUniversité Paris Cité, National Institute for Health and Medical Research (INSERM) CIC 1417 Cochin Pasteur, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France. odile.launay@aphp.fr.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19COVID-19 VaccinesHumansSARS-CoV-2Spike Glycoprotein, CoronavirusCOVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2
Identifiers
PMID
35513532What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.